Navigation Links
Novel Investigational Drug May Help American Women Suffering from Breast Pain

A clinical trial for a much needed treatment option for pain associated with fibrocystic breast disease, is in progress nationwide. The severely debilitating symptoms such as breast pain, affects about 26 million women in the United States alone but is often left untreated leaving women feeling hopeless.

As many as 50% of American women talk to their physician about breast pain including swelling, tenderness and lumps that increase prior and during menstruation and may continue for several days. The pain is not only physical. Psychological stress is often associated with undergoing mammograms, ultrasound scans and breast biopsies, techniques frequently utilized by physicians to rule out other diseases of the breast.

"Breast pain associated with fibrocystic breast disease can be physically impairing, leaving women unable to cope with basic daily functions, yet 85% of women don't receive treatment," said Gerianne Tringali DiPiano, President and CEO of FemmePharma Global Healthcare, the company sponsoring the study. "We hope news of this trial will compel women with breast pain associated with fibrocystic breast disease who have been previously diagnosed to seek a study center in their area."

Physicians at centers nationwide will enroll women who have breast pain associated with fibrocystic breast disease.

"The trial allows us to assess a new dosage form of an active pharmaceutical ingredient with a demonstrated safety and efficacy profile. We expect that the new dosage forms will provide a new treatment option for this very important disease state," added Bruce J. Levine MD, FACOG, and investigator of the trial.

About Breast Pain

Breast pain can impair a woman's ability to work, participate in her daily activities, embrace a child or have an intimate relationship with her partner. In addition, breast pain frequently causes increased anxiety and stress in a woman's life as a res ult of dealing with pain each month.

Approximately 15% of women who experience breast pain require prescription medication. Currently there is only one FDA approved prescription medication for pain associated with fibrocystic breast disease. However, this medication typically produces unwanted systemic side effects, which often causes women to stop their necessary treatment. In many cases, women are sent home and told to ice their breasts or purchase a tighter fitting brassiere leaving them feeling hopeless.


'"/>




Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... The Compretta Insurance Agency, a ... clients in and around the Hancock County area, is announcing the launch of a ... Pantry. , The Hancock County Food Pantry has worked for more than 30 years ...
(Date:12/8/2016)... ... 2016 , ... Bill Mull Agencies, a Wichita-based firm offering ... central Kansas, is joining the Youth Horizons organization for a charity event that ... Wichita, Youth Horizons works to empower area children from unstable, troubled, or single-parent ...
(Date:12/7/2016)... ... December 07, 2016 , ... Students ... have the unique opportunity to get hands-on experience in an emergency medical simulation, ... immersive experience to gain invaluable, real-life medical skills that are critical success in ...
(Date:12/7/2016)... Kenosha, Wisconsin (PRWEB) , ... December 07, 2016 , ... ... the extraordinary new MedMaster™ MPCNGX . The MPCNGX is a multi-function, sealed, LED ... the right amount of light where and when it’s needed. , A ...
(Date:12/7/2016)... ... December 07, 2016 , ... Silhouette ... deep lines by smoothing and tightening the skin of the face to create ... address facial aging with very little downtime, Silhouette Instalift is a novel, minimally ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016 According to a ... Product (Actual Sugars, Sugar Alcohols, Artificial Sweeteners), Type ... Agents), Formulation (Oral, Topical, Parenteral) - Global Forecast ... witnessed healthy growth during the last decade, and ... 4.3% between 2016 and 2021 to reach USD ...
(Date:12/8/2016)... 8, 2016  Hanson Research, an innovative leader ... and diffusion testing instruments for the pharmaceutical industry, ... Instruments, Inc. ("Teledyne"). The move is designed to ... testing instruments, as well as expand resources for ... products and services. Logo - http://photos.prnewswire.com/prnh/20161208/446988LOGO ...
(Date:12/8/2016)... LITTLE FALLS, N.J., Dec. 8, 2016 CANTEL MEDICAL ... net income of $18,800,000, or $0.45 per diluted share, on ... the first quarter ended October 31, 2016. This compares with ... sales of $153,779,000 for the first quarter ended October 31, ... the first quarter ended October 31, 2016 to $21,323,000, or ...
Breaking Medicine Technology: